A detailed history of Group One Trading, L.P. transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 10,116 shares of VTYX stock, worth $18,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,116
Previous 41,611 75.69%
Holding current value
$18,714
Previous $96,000 77.08%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.85 - $3.2 $58,265 - $100,784
-31,495 Reduced 75.69%
10,116 $22,000
Q2 2024

Aug 14, 2024

SELL
$2.31 - $5.59 $50,258 - $121,621
-21,757 Reduced 34.33%
41,611 $96,000
Q1 2024

May 10, 2024

SELL
$1.9 - $10.13 $493,203 - $2.63 Million
-259,581 Reduced 80.38%
63,368 $348,000
Q4 2023

Feb 14, 2024

BUY
$2.08 - $31.18 $671,733 - $10.1 Million
322,949 New
322,949 $797,000

Others Institutions Holding VTYX

About Ventyx Biosciences, Inc.


  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $105M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.